RE:RE:RE:RE:RE:RE:RE:Connections with the MNCDermTech spent millions in order to get a reimbursement code in the USA which has helped with their sales. If you study their numbers closely the Dermatologists have not accepted their service as particularly useful and now DermTech has pivoted and is building a sales force to try and sell their genetic testing kit for ONLY melanoma to doctors. They are burning a lot of money to achieve the sales they have and in my mind it certainly does not support a billion dollar market cap so time will tell but it is a little earlier in the game to declare them the winner in this space.
I am fully behind your comments MedX needs to increase it communication to shareholders and also start to show some traction of its technology in the market.
Have a great long weekend.